{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:46:50Z","timestamp":1788929210673,"version":"build-2803163510"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>Intracerebral hemorrhage carries high mortality and long-term disability. The optimal blood pressure (BP) management strategy\u2014aggressive vs. conservative lowering\u2014remains uncertain. This review compares both strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES:<\/jats:title>\n                    <jats:p>Articles from PubMed, Web of Science, Embase, and Cochrane were screened to August 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY SELECTION:<\/jats:title>\n                    <jats:p>Only randomized open-label blinded-endpoint trials were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA EXTRACTION:<\/jats:title>\n                    <jats:p>Patient characteristics, inclusion criteria, interventions, and outcomes were independently extracted by two authors; conflicts were resolved by a third.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SYNTHESIS:<\/jats:title>\n                    <jats:p>\n                      Eight randomized controlled trials (12,669 patients; median age 63 yr; 60% male) met inclusion. No significant differences emerged between aggressive and conservative strategies for excellent functional outcome (risk ratio [RR], 1.07; 95% CI, 0.99\u20131.16;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.94;\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 33%), good functional outcome (RR, 1.09; 95% CI, 0.99\u20131.20;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.07;\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 51%), 90-day mortality (RR, 0.90; 95% CI, 0.77\u20131.05;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.18;\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 0%), or hematoma growth (RR, 0.85; 95% CI, 0.66\u20131.10;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.22;\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 48%). Aggressive BP lowering was associated with fewer adverse events (RR, 0.87; 95% CI, 0.76\u20130.99;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.03;\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 59%). Sensitivity analyses showed significant benefits of the aggressive approach for good recovery (RR, 1.05; 95% CI, 1.01\u20131.10;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.02;\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 0%), although not confirmed in the subgroup analyses (RR, 1.09; 95% CI, 0.97\u20131.23;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.14;\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 61%). For adverse events, subgroup analyses consistently favored the aggressive strategy (RR, 0.81; 95% CI, 0.74\u20130.88;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.01;\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 0%). No clear association with hematoma growth emerged, largely due to heterogeneity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Aggressive and conservative BP lowering yielded similar outcomes for functional recovery, mortality, and hematoma growth. Aggressive BP lowering was linked to fewer adverse events, with some subgroup analyses suggesting modest functional benefits.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000007240","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:03:57Z","timestamp":1784729037000},"page":"2410-2418","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Aggressive vs. Conservative Blood Pressure Reduction in Acute Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1097","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6242-7279","authenticated-orcid":false,"given":"Gabriel","family":"Semione","sequence":"first","affiliation":[{"name":"Department of Medicine, University of West Santa Catarina, Joa\u00e7aba, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio Yuri","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Deparment of Neurosurgery, Northwell, New Hyde Park, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Gunkan","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Vilardo","sequence":"additional","affiliation":[{"name":"Department of Medicine, School of Medicine, Catholic University of Brasilia, Bras\u00edlia, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Henrique da Silva","family":"Tobaldini","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of West Santa Catarina, Joa\u00e7aba, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Lebkuchen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Adauto Botelho Hospital, Pinhais, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Januario Campos","family":"Cardoso","sequence":"additional","affiliation":[{"name":"Department of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhon E.","family":"Bocanegra-Becerra","sequence":"additional","affiliation":[{"name":"Academic Department of Surgery, School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Bertani","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wellingson","family":"Paiva","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Deparment of Neurosurgery, Northwell, New Hyde Park, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Langer","sequence":"additional","affiliation":[{"name":"Deparment of Neurosurgery, Northwell, New Hyde Park, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Netanel","family":"Ben-Shalom","sequence":"additional","affiliation":[{"name":"Deparment of Neurosurgery, Northwell, New Hyde Park, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"R1-20260908","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1603460","article-title":"Intensive blood-pressure lowering in patients with acute cerebral hemorrhage.","volume":"375","author":"Qureshi","year":"2016","journal-title":"N Engl J Med"},{"key":"R2-20260908","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/CCM.0b013e3181b9e1a5","article-title":"Antihypertensive treatment of acute cerebral hemorrhage.","volume":"38","year":"2010","journal-title":"Crit Care Med"},{"key":"R3-20260908","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/1747493020932784","article-title":"Controlling Hypertension After Severe Cerebrovascular Event (CHASE): A randomized, multicenter, controlled study.","volume":"16","author":"Yuan","year":"2021","journal-title":"Int J Stroke"},{"key":"R4-20260908","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/STROKEAHA.114.005614","article-title":"Acute blood pressure reduction in patients with intracerebral hemorrhage does not result in borderzone region hypoperfusion.","volume":"45","author":"Gould","year":"2014","journal-title":"Stroke"},{"key":"R5-20260908","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/STROKEAHA.111.000188","article-title":"The intracerebral hemorrhage acutely decreasing arterial pressure trial.","volume":"44","author":"Butcher","year":"2013","journal-title":"Stroke"},{"key":"R6-20260908","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(08)70069-3","article-title":"Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): A randomised pilot trial.","volume":"7","author":"Anderson","year":"2008","journal-title":"Lancet Neurol"},{"key":"R7-20260908","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMoa1214609","article-title":"Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage.","volume":"368","author":"Anderson","year":"2013","journal-title":"N Engl J Med"},{"key":"R8-20260908","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(23)00806-1","article-title":"The third intensive care bundle with blood pressure reduction in acute cerebral haemorrhage trial (INTERACT3): An international, stepped wedge cluster randomised controlled trial.","volume":"402","author":"Ma","year":"2023","journal-title":"Lancet"},{"key":"R9-20260908","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJMoa2314741","article-title":"Intensive ambulance-delivered blood-pressure reduction in hyperacute stroke.","volume":"390","author":"Li","year":"2024","journal-title":"N Engl J Med"},{"key":"R10-20260908","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s12028-008-9085-8","article-title":"Rapid blood pressure reduction in acute intracerebral hemorrhage: Feasibility and safety.","volume":"8","author":"Koch","year":"2008","journal-title":"Neurocrit Care"},{"key":"R11-20260908","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R13-20260908","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R14-20260908","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5414\/CP203542","article-title":"A clinical study on the association of clinical outcome and acute systolic blood pressure in cerebral hemorrhage patients.","volume":"58","author":"Kan","year":"2020","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R15-20260908","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.mjafi.2017.03.010","article-title":"Randomized trial to assess safety and clinical efficacy of intensive blood pressure reduction in acute spontaneous intracerebral haemorrhage.","volume":"74","author":"Gupta","year":"2018","journal-title":"Med J Armed Forces India"},{"key":"R16-20260908","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/STROKEAHA.116.014285","article-title":"Perioperative antihypertensive treatment in patients with spontaneous intracerebral hemorrhage.","volume":"48","author":"Zheng","year":"2017","journal-title":"Stroke"},{"key":"R18-20260908","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1097\/HJH.0b013e328300a24a","article-title":"Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China.","volume":"26","author":"Zhang","year":"2008","journal-title":"J Hypertens"},{"key":"R19-20260908","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S1474-4422(14)70018-3","article-title":"Blood pressure variability and outcome after acute intracerebral haemorrhage: A post-hoc analysis of INTERACT2, a randomised controlled trial.","volume":"13","author":"Manning","year":"2014","journal-title":"Lancet Neurol"},{"key":"R20-20260908","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1161\/STROKEAHA.119.025514","article-title":"Blood pressure variability predicts poor in-hospital outcome in spontaneous intracerebral hemorrhage.","volume":"50","author":"Divani","year":"2019","journal-title":"Stroke"},{"key":"R21-20260908","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","article-title":"2022 Guideline for the management of patients with spontaneous intracerebral hemorrhage: A guideline from the American Heart Association\/American Stroke Association.","volume":"53","author":"Greenberg","year":"2022","journal-title":"Stroke"},{"key":"R22-20260908","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1161\/01.STR.0000131807.54742.1a","article-title":"Perihematomal edema in primary intracerebral hemorrhage is plasma derived.","volume":"35","author":"Butcher","year":"2004","journal-title":"Stroke"},{"key":"R23-20260908","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1161\/STROKEAHA.113.001306","article-title":"Autoregulation of cerebral blood flow is preserved in primary intracerebral hemorrhage.","volume":"44","author":"Gould","year":"2013","journal-title":"Stroke"},{"key":"R24-20260908","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0885066604271619","article-title":"A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage.","volume":"20","author":"Qureshi","year":"2005","journal-title":"J Intensive Care Med"},{"key":"R25-20260908","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archneurol.2010.61","article-title":"Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: Results from the antihypertensive treatment of acute cerebral hemorrhage study.","volume":"67","author":"Qureshi","year":"2010","journal-title":"Arch Neurol"},{"key":"R26-20260908","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1212\/01.wnl.0000208408.98482.99","article-title":"Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.","volume":"66","author":"Davis","year":"2006","journal-title":"Neurology"},{"key":"R27-20260908","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S1474-4422(19)30196-6","article-title":"Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: A preplanned pooled analysis of individual participant data.","volume":"18","author":"Moullaali","year":"2019","journal-title":"Lancet Neurol"},{"key":"R28-20260908","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jnnp-2021-327195","article-title":"Early lowering of blood pressure after acute intracerebral haemorrhage: A systematic review and meta-analysis of individual patient data.","volume":"93","author":"Moullaali","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R29-20260908","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s12028-025-02325-x","article-title":"Intensive blood pressure lowering for intracerebral hemorrhage: A systematic review and updated meta-analysis of randomized controlled trials.","volume":"43","author":"Reginato","year":"2025","journal-title":"Neurocrit Care"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:00:45Z","timestamp":1788886845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000007240","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]}}}